SCHEMBL7544774

SCHEMBL7544774

c1cncc(CSCC2CCCN2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.47
CHRNA4 P43681 4/20 0.47
CHRNA7 P36544 2/20 0.47
CHRM2 P08172 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
MEN1 O00255 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7552181 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL7544770 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL2981954 0.81 POLB (0.58) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
Hydrochloric Acid SCHEMBL3552773 0.80 POLB (0.57) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL27267830 0.78 CHRNB2 (0.54) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL7544823 0.75 CHRNB2 (0.60) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL7552821 0.75 CHRNB2 (0.60) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL7544820 0.75 CHRNB2 (0.60) CHRNB2CHRNA4CHRNA7CHRM2CHRM1
SCHEMBL19089215 0.74 HRH1 (0.50) CHRNB2CHRNA4CHRNA7CYP2A6
SCHEMBL8550485 0.74 CHRNB2 (0.51) CHRNB2CHRNA4CHRNA7MEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212301-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS Targacept, Inc. (US) 2002-06-12 EP disclosed
EP-1212301-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS Targacept, Inc. (US) 2002-06-12 EP disclosed
WO-2001016107-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS TARGACEPT, INC. (US) 2001-03-08 WO disclosed
WO-2001016107-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS TARGACEPT, INC. (US) 2001-03-08 WO disclosed